Enovis (ENOV) Current Assets (2010 - 2026)
Enovis' (ENOV) quarterly Current Assets came in at $1.2 billion in Q2 2026, up 1.76% year-on-year from $1.2 billion in Q2 2025, and up 2.7% on a QoQ basis from $1.2 billion in Q4 2025.
Enovis (ENOV) Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Current Assets data on file, last reported at $1.2 billion in Q2 2026.
- On a quarterly basis, Current Assets rose 1.76% year-over-year to $1.2 billion in Q2 2026; TTM through Apr 2026 was $1.2 billion, a 1.76% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 5.29% from the prior year.
- Current Assets for Q2 2026 stood at $1.2 billion, up from $1.2 billion in the prior quarter.
- Over the last five years, Current Assets for ENOV reached as high as $2.3 billion in Q2 2022 and fell as low as $795.0 million in Q4 2022.
- Historically, Current Assets has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
- Across the five-year window, Current Assets plunged 65.48% in 2022 and soared 40.84% in 2024, its largest moves.
- Year by year, Current Assets stood at $795.0 million in 2022, then climbed by 12.77% to $896.5 million in 2023, then increased by 27.88% to $1.1 billion in 2024, then climbed by 5.29% to $1.2 billion in 2025, then grew by 2.7% to $1.2 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $1.2 billion in Q2 2026, $1.2 billion in Q4 2025, and $1.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 1.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Oct 3, 2025 | 1.28 Bn |
| Jul 4, 2025 | 1.28 Bn |
| Apr 4, 2025 | 1.22 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 27, 2024 | 1.20 Bn |
| Jun 28, 2024 | 1.17 Bn |
| Mar 29, 2024 | 1.15 Bn |
| Dec 31, 2023 | 896.52 Mn |
| Sep 29, 2023 | 854.19 Mn |
| Jun 30, 2023 | 887.24 Mn |
| Mar 31, 2023 | 833.11 Mn |
| Dec 31, 2022 | 795.02 Mn |
| Sep 30, 2022 | 1.01 Bn |
| Jul 1, 2022 | 1.08 Bn |
| Apr 1, 2022 | 2.35 Bn |
| Dec 31, 2021 | 2.30 Bn |
| Oct 1, 2021 | 1.73 Bn |
| Jul 2, 2021 | 1.48 Bn |